BioAmber Inc fka BIOAQ

[Koan]

Call your broker and ask for someone familiar with Corporate Actions or from their Reorg Department.

They will then direct you to one of several contacts attached to the CUSIP Suspension.

Additionally, there has yet to be publicly filed a Discharge Certificate, which according to the most recent Canadian judgement is required to officially terminate the CCAA proceedings.

PwC refuses to answer any questions with definitive specificity, even outside of Chapter 15 and the subsequent CUSIP Suspension. Should you have any questions, this is PwC's default answer:

CCAA
Page last updated: July 3, 2019

This page is for information purposes only and you should consult your professional adviser if you have any questions or are uncertain as to your rights or obligations.

For efficiency and confidentiality purposes, the Monitor cannot respond to the many questions submitted by BioAmber’s shareholders.

Do Govern Yourselves Accordingly